240 related articles for article (PubMed ID: 7949202)
41. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC; To SQ; Simpson ER; Clyne CD
Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
[TBL] [Abstract][Full Text] [Related]
43. Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells.
Zhou D; Clarke P; Wang J; Chen S
J Biol Chem; 1996 Jun; 271(25):15194-202. PubMed ID: 8662988
[TBL] [Abstract][Full Text] [Related]
44. Breast tumor aromatase: functional role and transcriptional regulation.
Chen S; Zhou D; Okubo T; Kao YC; Yang C
Endocr Relat Cancer; 1999 Jun; 6(2):149-56. PubMed ID: 10731103
[TBL] [Abstract][Full Text] [Related]
45. Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage.
Simpson ER; Michael MD; Agarwal VR; Hinshelwood MM; Bulun SE; Zhao Y
FASEB J; 1997 Jan; 11(1):29-36. PubMed ID: 9034163
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
[TBL] [Abstract][Full Text] [Related]
47. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
48. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
49. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
50. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
[TBL] [Abstract][Full Text] [Related]
51. Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer.
Harada N; Utsumi T; Takagi Y
Pharmacogenetics; 1995; 5 Spec No():S59-64. PubMed ID: 7581491
[TBL] [Abstract][Full Text] [Related]
52. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells.
Mu YM; Yanase T; Nishi Y; Hirase N; Goto K; Takayanagi R; Nawata H
Mol Cell Endocrinol; 2000 Aug; 166(2):137-45. PubMed ID: 10996432
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional regulation of aromatase expression in human breast tissue.
Chen S; Itoh T; Wu K; Zhou D; Yang C
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):93-9. PubMed ID: 12650705
[TBL] [Abstract][Full Text] [Related]
54. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
55. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.
Zhou J; Suzuki T; Kovacic A; Saito R; Miki Y; Ishida T; Moriya T; Simpson ER; Sasano H; Clyne CD
Cancer Res; 2005 Jan; 65(2):657-63. PubMed ID: 15695411
[TBL] [Abstract][Full Text] [Related]
56. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
57. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues.
Toda K; Simpson ER; Mendelson CR; Shizuta Y; Kilgore MW
Mol Endocrinol; 1994 Feb; 8(2):210-7. PubMed ID: 8170477
[TBL] [Abstract][Full Text] [Related]
58. Aromatase activity and CYP19 gene expression in breast cancers.
Sourdaine P; Mullen P; White R; Telford J; Parker MG; Miller WR
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):191-8. PubMed ID: 9010334
[TBL] [Abstract][Full Text] [Related]
59. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
[TBL] [Abstract][Full Text] [Related]
60. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
